Near Field Electronics LLC v. CVS Pharmacy: NFC Patent Suit Dismissed With Prejudice in 132 Days
Near Field Electronics LLC filed suit in the Eastern District of Texas asserting five NFC and RFID patents against CVS Pharmacy’s credit card reader devices equipped with the NXP PN512 NFC front-end. The plaintiff voluntarily dismissed with prejudice after just 132 days, before CVS filed any answer — with each party bearing its own costs.
NFC patent assertion against CVS ends before defendant ever answered
Near Field Electronics LLC, a patent assertion entity holding a portfolio of NFC and RFID communication patents, filed suit against CVS Pharmacy, Inc. on June 18, 2025 in the Eastern District of Texas before Judge Michael J. Truncale. The complaint alleged infringement of five U.S. patents — US6996727B1, US6959350B1, US6742071B1, US6691201B1, and US7373531B2 — by CVS’s credit card reader devices equipped with the NXP PN512 NFC front-end integrated circuit.
On October 28, 2025, just 132 days after filing, Near Field Electronics voluntarily dismissed its action against CVS with prejudice pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i). The dismissal was filed before CVS had served any answer or motion for summary judgment, placing it squarely within the plaintiff’s right to dismiss unilaterally at that procedural stage. Critically, the dismissal was with prejudice, meaning Near Field Electronics permanently relinquished its right to re-assert these five patents against CVS.
The 132-day case duration and pre-answer resolution are consistent with an out-of-court settlement or licensing agreement, though the public record contains no confirmation of any financial terms. The with-prejudice designation, combined with each party bearing its own costs, suggests a negotiated resolution rather than a unilateral walk-away — but the underlying commercial terms, if any, remain undisclosed. The swift conclusion before CVS mounted any formal defense limits the public record on the technical merits of the infringement allegations.
Filing to Voluntary dismissal in 132 days
132 days — shorter than the median E.D. Texas patent case lifespan of ~2 years
Voluntary dismissal with prejudice: what the Rule 41 exit means for both parties
Rule 41(a)(1)(A)(i) dismissal with prejudice explained
Under FRCP 41(a)(1)(A)(i), a plaintiff may dismiss without a court order before the defendant serves an answer or motion for summary judgment. Near Field Electronics invoked this right but added ‘with prejudice’ — a self-imposed, permanent bar on re-filing the same claims against CVS. This is legally equivalent to a final judgment on the merits for preclusion purposes.
Plaintiff-initiated, no court order neededNear Field Electronics permanently bars itself from re-suing CVS on these patents
By dismissing with prejudice, Near Field Electronics surrendered all future infringement claims against CVS under all five asserted patents. This forecloses any re-filing if licensing talks later break down. If a negotiated licence was secured, the with-prejudice dismissal serves as the procedural close. If not, the plaintiff gave up significant leverage for no apparent judicial reason — suggesting a commercial resolution is the more probable explanation.
No re-filing rights against CVSCVS exits without admitting infringement and bears no court-ordered costs
CVS Pharmacy never filed an answer, meaning no invalidity counterclaims, no claim construction dispute, and no public record of its defence strategy. The cost-neutral terms mean CVS bears no judicial fee award. CVS retains full freedom to continue operating NXP PN512-equipped payment terminals absent any injunction or licence, unless a private licence was privately agreed. The public record does not establish whether CVS made any payment.
No liability admitted; litigation costs self-absorbedPre-answer NFC patent exits signal active licensing campaigns across retail
A five-patent NFC portfolio asserted against a major retailer’s payment terminals, resolved in 132 days before any substantive defence, is a pattern consistent with a licensing-first enforcement strategy. Other retailers and payment terminal operators using NXP PN512 or comparable NFC front-end chips should treat this case as a signal that Near Field Electronics’ portfolio is actively licensed. The five patents span multiple application numbers suggesting layered coverage of NFC communication methods.
NFC terminal operators: review exposure nowFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Near Field Electronics LLC | Company | NFC/RFID patent assertion entity — holder of US6996727B1 and four related NFC patentsSearch in Eureka ↗ |
| Defendant | CVS Pharmacy, Inc. | Company | CVS Pharmacy, Inc. — major U.S. retail pharmacy chain operating NFC-enabled payment terminalsSearch in Eureka ↗ |
| Plaintiff counsel | Robert Dean Kiddie , Jr. | Attorney | Counsel for Near Field Electronics LLCSearch in Eureka ↗ |
| Plaintiff counsel | Trevor James Beaty | Attorney | Counsel for Near Field Electronics LLCSearch in Eureka ↗ |
| Plaintiff law firm | Devlin Law Firm LLC (Wilmington) | Law Firm | Representing Near Field Electronics LLCSearch in Eureka ↗ |
| Plaintiff law firm | Shea Beaty | Law Firm | Representing Near Field Electronics LLCSearch in Eureka ↗ |
| Presiding judge | Judge Michael J. Truncale | Judge | Texas Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The dismissal notice invokes Rule 41(a)(1)(A)(i) precisely and adds the ‘with prejudice’ qualifier voluntarily — a choice that carries the force of a final merits judgment for claim preclusion. The cost-neutrality clause (‘each party shall bear its own costs’) is a negotiated term not required by the rule itself, suggesting mutual agreement on exit terms. No infringement finding, no invalidity ruling, and no claim construction record exist in the public docket. The technical merits of the NXP PN512 infringement allegations remain entirely unresolved on the public record.
US6996727B1 and four related NFC/RFID patents — contactless communication technology
The five asserted patents — US6996727B1, US6959350B1, US6742071B1, US6691201B1, and US7373531B2 — cover NFC and RFID contactless communication technologies filed across multiple application families (Application Nos. 09/649551, 10/186465, 09/625167, 09/598561, and 11/122123). These patents protect methods and systems for establishing short-range wireless communication between reader devices and contactless cards or tags — the foundational technology underpinning modern tap-to-pay and contactless access systems.
The NXP PN512 NFC front-end IC is a widely deployed chip in retail point-of-sale terminals, transit ticketing, and access control systems worldwide. Asserting five patents against a single device type suggests Near Field Electronics believes its portfolio covers core protocol-level or hardware-interface aspects of NFC communication rather than narrow product-specific features. This creates broad exposure for any operator of PN512-equipped terminals and for device manufacturers who have not secured licences from this portfolio.
Should you run an FTO against US6996727B1 and the Near Field Electronics NFC portfolio?
If your organisation deploys NFC-enabled payment terminals, contactless access readers, or tap-to-pay hardware incorporating the NXP PN512 or functionally equivalent NFC front-end chips, this case is directly relevant. Near Field Electronics has demonstrated active enforcement in E.D. Texas against a major retail operator. A freedom-to-operate analysis against all five asserted patents should be a priority for retail chains, transit authorities, healthcare payment operators, and OEMs supplying NFC reader hardware.
PatSnap Eureka’s FTO Search Agent can map each asserted claim across your product’s technical implementation, identify claim elements most likely to read on NXP PN512 architectures, and surface prior art that may bear on validity. With five patents across related families, understanding claim overlap and prosecution history estoppel is essential before concluding any FTO is clean. Eureka accelerates that multi-patent analysis from weeks to hours.
Run a freedom-to-operate analysis on US6996727B1 to assess your product’s exposure
Run FTO in Eureka →Similar NFC and RFID patent infringement cases in E.D. Texas
Cases involving NFC and RFID contactless communication patents litigated in the Eastern District of Texas against retail and payment terminal operators.
What this case signals for the NFC payment technology IP landscape
A fast, with-prejudice exit in E.D. Texas before any answer points to a calculated licensing play across the retail payment sector.
Pre-answer dismissals with prejudice often signal a settled licence — not defeat
When a plaintiff voluntarily exits with prejudice before the defendant answers, it typically signals a negotiated outcome. The with-prejudice term protects the defendant commercially while allowing the plaintiff to report a resolved matter. Retail and payment terminal operators facing similar assertions should treat pre-answer resolution as a common endgame in NFC patent campaigns.
Five-patent NFC portfolios create layered infringement risk for POS terminal operators
Near Field Electronics asserted patents across multiple application families covering NFC and RFID communication. This layered approach makes design-arounds more difficult and raises the cost of defence. Any company deploying NXP PN512 or similar NFC front-end chips in point-of-sale, access control, or contactless payment devices should conduct an FTO review against this portfolio.
Near v CVS — key questions answered
The with-prejudice dismissal means Near Field Electronics permanently forfeited its right to sue CVS Pharmacy again on these five NFC patents. It does not affect Near Field Electronics’ ability to assert the same patents against other defendants. CVS received a final bar on these specific claims without any court adjudication of infringement or validity.
Near Field Electronics asserted five U.S. patents: US6996727B1 (App. No. 09/649551), US6959350B1 (App. No. 10/186465), US6742071B1 (App. No. 09/625167), US6691201B1 (App. No. 09/598561), and US7373531B2 (App. No. 11/122123). All cover NFC and RFID contactless communication technology relevant to credit card reader devices using the NXP PN512 NFC front-end IC.
The NXP PN512 is a widely used NFC front-end integrated circuit deployed in retail payment terminals, transit systems, and access control readers. Near Field Electronics specifically identified CVS credit card reader devices equipped with the PN512 as the accused products. This chip’s broad market penetration means the asserted patents could have implications for many other operators using the same or comparable hardware.
CVS Pharmacy never faced a judgment. The plaintiff voluntarily dismissed with prejudice before CVS filed any answer. CVS admitted no infringement, no invalidity finding was made, and no costs were awarded against either party. Whether a confidential licence or settlement payment was involved is not disclosed in the public record.
The Eastern District of Texas is a historically plaintiff-favoured venue for patent infringement suits, known for streamlined patent procedures and plaintiff-friendly jury pools. Patent assertion entities frequently select E.D. Texas to maximise settlement pressure on defendants. The case was assigned to Judge Michael J. Truncale. The 132-day resolution before any answer is consistent with the forum’s reputation for accelerating commercial resolution.
PatSnap Eureka searches patents and litigation data to answer instantly.